Home / Dr. Soliman Abdel Kader Fakeeh Hospital Co. / 2024 Annual Results

Dr. Soliman Abdel Kader Fakeeh Hospital Co. 2024 Annual Results

Revenue

SAR 2.79B

Net Profit

SAR 264M

EPS

SAR 1.32

Operating Cash Flow

SAR 436M

Dr. Soliman Abdel Kader Fakeeh Hospital Co. (4017) reported full year 2024 revenue of SAR 2.79B, up 19.9% from SAR 2.33B in 2023. Net profit came in at SAR 264M, up 13.6% year on year. Earnings per share were SAR 1.32. The company generated SAR 436M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.65 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.65.

Key Financial Metrics

Metric	2024	2023
Revenue	SAR 2.79B	SAR 2.33B
Net Profit	SAR 264M	SAR 232M
Net Margin	9.4%	10.0%
ROE	8.9%	22.7%
EPS	SAR 1.32	SAR 1.40
Total Assets	SAR 5.32B	SAR 4.23B
Total Equity	SAR 2.95B	SAR 1.02B
Total Liabilities	SAR 2.00B	SAR 2.98B
Operating Cash Flow	SAR 436M	SAR 229M

Year on Year Comparison

Revenue increased by 19.9% compared to 2023. Net profit increased by 13.6%. Both revenue and profit grew — indicating expanding business.

View full company profile →

View all years:

2025 2024 2023

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-03-04.